Celgene Corporation · Summit, NJ United States (NASDAQ: CELG)
Key Celgene Corporation Financials
| Company Type | Public -(NASDAQ: CELG) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2000 Sales (mil.) | $84.2 |
| 2010 Employees | 4,182 |
Celgene Corporation Income Statement
| Dec 00 | Dec 99 | Dec 87 | |
| Revenue | 84.2 | 26.2 | 0.4 |
| Cost of Goods Sold | 4.6 | 3.0 | -- |
| Gross Profit | 79.6 | 23.2 | 0.4 |
| Gross Profit Margin | 94.5% | 88.6% | -- |
| SG&A Expense | 49.9 | 26.2 | -- |
| Depreciation & Amortization | 4.7 | 1.0 | -- |
| Operating Income | (27.6) | (22.0) | -- |
| Operating Margin | -32.8% | -83.8% | --% |
| Nonoperating Income | (6.7) | 0.0 | -- |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | -- | (24.8) | -- |
| Income Taxes | (1.8) | (3.0) | -- |
| Net Income After Taxes | 1.8 | (21.8) | 0.0 |
| Continuing Operations | (17.0) | (21.8) | -- |
| Discontinued Operations | 0.7 | 0.0 | -- |
| Total Operations | (16.3) | (21.8) | -- |
| Total Net Income | (16.3) | (21.8) | (4.3) |
| Net Profit Margin | -19.3% | -83.1% | -1075% |
| Diluted EPS from Total Net Income | (0.06) | (0.11) | (0.95) |
| Dividends per Share | -- | -- | 0.0 |
All amounts in millions of US Dollars except per share amounts.
Celgene Corporation Balance Sheet
| Assets | Dec 00 | Dec 99 | Dec 87 |
| Current Assets | |||
| Cash | 161.4 | 15.3 | 26.4 |
| Net Receivables | 9.8 | 4.9 | -- |
| Inventories | 4.3 | 2.5 | -- |
| Other Current Assets | 156.5 | 5.2 | -- |
| Total Current Assets | 332.0 | 27.8 | 26.6 |
| Net Fixed Assets | 8.4 | 2.3 | -- |
| Other Noncurrent Assets | 6.3 | 2.2 | -- |
| Total Assets | 346.7 | 32.3 | 30.2 |
| Liabilities | Dec 00 | Dec 99 | Dec 87 |
| Current Liabilities | |||
| Accounts Payable | 10.9 | 2.4 | -- |
| Short-Term Debt | 0.9 | 0.2 | -- |
| Other Current Liabilities | 22.0 | 6.8 | -- |
| Total Current Liabilities | 33.8 | 9.3 | 0.8 |
| Long-Term Debt | 12.3 | 38.5 | 0.0 |
| Other Noncurrent Liabilities | 5.1 | 0.2 | -- |
| Total Liabilities | 51.2 | 48.0 | -- |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | 0.0 | -- |
| Common Stock Equity | 295.5 | (15.7) | -- |
| Total Equity | 295.5 | (15.7) | 29.4 |
| Shares Outstanding (thou.) | 470,640.4 | 459,602.4 | 5.2 |
All amounts in millions of US Dollars except per share amounts.
Celgene Corporation Cash Flow Statement
| Dec 00 | Dec 99 | Dec 87 | |
| Net Operating Cash Flow | (1) | (21) | -- |
| Net Investing Cash Flow | (145.6) | (4.5) | -- |
| Net Financing Cash Flow | 286.6 | 37.4 | |
| Net Change in Cash | 139.5 | 12.2 | |
| Depreciation & Amortization | 4.7 | 1.0 | |
| Capital Expenditures | (9.6) | (1.8) | |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.